查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786987

週边动脉疾病市场，规模，占有率，趋势，产业分析报告:治疗类别，各流通管道，各终端用户，各地区- 市场预测，2025年～2034年

Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，週边动脉疾病 (PAD) 市场规模预计到 2034 年将达到 105.3 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

週边动脉疾病 (PAD) 市场专注于週边动脉粥状硬化阻塞的诊断、治疗和管理，主要影响下肢。这种疾病会导致血流减少，进而引起疼痛、组织损伤，严重时甚至需要截肢。糖尿病、高血压、吸烟和肥胖等风险因素的日益流行，正在扩大目标人群，并推动对有效 PAD 治疗的需求。血管影像和早期诊断工具的进步正在提高检出率，而微创治疗的转变使得血管内治疗优于传统手术。药物洗脱支架、球囊血管成形术和动脉粥状硬化斑块切除系统等技术进步正在改善患者的预后和手术效率。针对疾病严重程度和患者合併症的联合疗法和个人化治疗方法的发展进一步推动了市场的发展。

数位健康平台与血管护理的整合实现了远端监控、治疗依从性和数据驱动的干预。对研究和临床试验的大力投资持续推动技术创新，尤其是在抗再狭窄器械和生物可吸收植入物方面。医疗保健提供者、医疗技术公司和研究机构之间的策略联盟正在促进先进週边动脉疾病 (PAD) 解决方案的商业化。此外，宣传活动和筛检计划鼓励早期干预并扩大潜在市场。对基于价值的护理和以患者为中心的护理模式的日益重视，正在推动具有成本效益、以结果为导向的外周动脉疾病 (PAD) 治疗的重要性。市场竞争和技术创新仍然激烈，为致力于解决週边血管疾病管理领域未满足需求的利害关係人提供了庞大的商机。

週边动脉疾病市场报告重点

按治疗类型划分，预计到2024年，器械细分市场的收入将占到总收入的约62%，因为支架、血管成形术球囊和微创动脉粥样硬化切除器械的日益普及将推动市场需求的强劲增长。

按分销管道划分，预计到2024年，医院药房细分市场的收入将占到最大占有率，因为大量患者涌入医院进行复杂的外周动脉疾病 (PAD) 干预，例如血管成形术和搭桥手术，这将进一步推动医院药房占主导地位。

预计亚太地区将在2025年至2034年期间经历显着增长，这得益于医疗保健体系的快速扩张、可支配收入的增加以及健康意识的增强，这些因素都将促进外周动脉疾病 (PAD) 筛检和诊断的改善。率。

由于糖尿病、肥胖和吸烟等心血管危险因子的普遍性，预计北美週边动脉疾病市场将在 2024 年占最大的收入占有率。

主要的全球公司包括 Amedisys, Inc.、B. Braun SE、Baxter、BD、CareCentrix, Inc.、Coram LLC.、Fresenius Kabi AG、ICU Medical, Inc.、JMS Co. Ltd.、Moog Inc.、Option Care Health, Inc.、PharMerica Corporation 和 Terumo Corporation。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球週边动脉疾病市场洞察

  • 市场概况
  • 週边动脉疾病市场动态
    • 驱动因素与机遇
      • 糖尿病和高血压盛行率上升
      • 全球人口老化
    • 限制与挑战
      • 治疗费用高。
  • PESTEL分析
  • 週边动脉疾病的市场趋势
  • 价值链分析

第5章 全球週边动脉疾病市场:治疗类别

  • 主要调查结果
  • 简介
  • 设备
  • 药物类型

第6章 全球週边动脉疾病市场:各流通管道

  • 主要调查结果
  • 简介
  • 医院药局
  • 零售药局
  • 其他

第7章 全球週边动脉疾病市场:各终端用户

  • 主要调查结果
  • 简介
  • 医院
  • 专门诊所
  • 门诊病人手术中心

第8章 全球週边动脉疾病市场:地区

  • 主要调查结果
  • 简介
    • 週边动脉疾病市场评估:地区，2020年～2034年
  • 北美
    • 北美:治疗类别，2020年～2034年
    • 北美:各流通管道，2020年～2034年
    • 北美:各终端用户，2020年～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:治疗类别，2020年～2034年
    • 欧洲:各流通管道，2020年～2034年
    • 欧洲:各终端用户，2020年～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:治疗类别，2020年～2034年
    • 亚太地区:各流通管道，2020年～2034年
    • 亚太地区:各终端用户，2020年～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:治疗类别，2020年～2034年
    • 中东·非洲:各流通管道，2020年～2034年
    • 中东·非洲:各终端用户，2020年～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:治疗类别，2020年～2034年
    • 南美:各流通管道，2020年～2034年
    • 南美:各终端用户，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Abbott
  • AngioDynamics
  • B. Braun SE
  • Bayer AG
  • BD
  • Biotronik
  • Boston Scientific Corporation
  • Cardinal Health
  • Endologix LLC
  • iVascular
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medtronic
  • Terumo Corporation
Product Code: PM6022

The peripheral artery disease (PAD) market size is expected to reach USD 10.53 billion by 2034, according to a new study by Polaris Market Research. The report "Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034," gives a detailed insight into current market dynamics and provides analysis on future market growth.

The peripheral artery disease (PAD) market focuses on the diagnosis, treatment, and management of atherosclerotic blockages in the peripheral arteries, primarily affecting the lower extremities. This condition leads to reduced blood flow, causing pain, tissue damage, and in severe cases, limb amputation. The increasing prevalence of risk factors such as diabetes, hypertension, smoking, and obesity is expanding the target population and fueling demand for effective PAD therapies. Advancements in vascular imaging and early diagnostic tools are improving detection rates, while the shift toward minimally invasive procedures is driving preference for endovascular treatments over traditional surgery. Technological progress in drug-eluting stents, balloon angioplasty, and atherectomy systems is enhancing patient outcomes and procedural efficiency. Market growth is further supported by the development of combination therapies and personalized treatment approaches tailored to disease severity and patient comorbidities.

The integration of digital health platforms into vascular care is enabling remote monitoring, treatment adherence, and data-driven interventions. Strong investments in research and clinical trials continue to shape innovation, particularly in anti-restenosis devices and bioresorbable implants. Strategic collaborations among healthcare providers, medtech firms, and research institutions are fostering the commercialization of advanced PAD solutions. In addition, increasing awareness campaigns and screening initiatives are encouraging earlier intervention, thus expanding the addressable market. Growing emphasis on value-based care and patient-centric treatment models is reinforcing the importance of cost-effective and outcome-driven PAD therapies. The market remains competitive and innovation-driven, presenting substantial opportunities for stakeholders committed to addressing unmet needs in peripheral vascular disease management.

Peripheral Artery Disease Market Report Highlights

By treatment type, the device segment accounted for ~62% of the revenue share in 2024, due to the wider adoption of stents, angioplasty balloons, and atherectomy devices for minimally invasive procedures is contributing to strong demand in the device segment.

Based on distribution channel, the hospital pharmacy segment accounted for the largest revenue share in 2024 due to the high patient inflow for complex PAD interventions, such as angioplasty or bypass surgeries, contributes to the dominance of hospital pharmacies.

Asia Pacific is expected to grow significantly from 2025 to 2034 due to rapidly expanding healthcare systems, rising disposable income, and growing health awareness are contributing to improved PAD screening and diagnosis rates.

The North America peripheral artery disease market accounted for the largest revenue share in 2024 due to the high prevalence of cardiovascular risk factors, such as diabetes, obesity, and smoking, has increased the burden of peripheral artery disease across the region.

A few global key players include Amedisys, Inc.; B. Braun SE; Baxter; BD; CareCentrix, Inc.; Coram LLC.; Fresenius Kabi AG; ICU Medical, Inc.; JMS Co. Ltd.; Moog Inc.; Option Care Health, Inc.; PharMerica Corporation; and Terumo Corporation.

Polaris Market Research has segmented the peripheral artery disease market report on the basis of treatment type, distribution channel, end user, and region:

By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)

Device

Balloon Catheters

Plaque Modification Devices

Stents

Atherectomy Devices

Guidewires and Sheaths

Other Devices

Drug Type

Lipid-lowering Drugs

Antiplatelet Drugs

Thrombolytic Agents

Triple-H Therapy

Other Drugs

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacy

Retail Pharmacy

Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospital

Specialty Clinics

Ambulatory Surgical Centers

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Peripheral Artery Disease Market Insights

  • 4.1. Peripheral Artery Disease Market - Market Snapshot
  • 4.2. Peripheral Artery Disease Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Diabetes and Hypertension
      • 4.2.1.2. Aging Global Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High treatment costs.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Peripheral Artery Disease Market Trends
  • 4.6. Value Chain Analysis

5. Global Peripheral Artery Disease Market, by Treatment Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • 5.3. Device
    • 5.3.1. Global Peripheral Artery Disease Market, by Device, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Balloon Catheters
      • 5.3.2.1. Global Peripheral Artery Disease Market, by Balloon Catheters, 2020-2034 (USD Billion)
    • 5.3.3. Plaque Modification Devices
      • 5.3.3.1. Global Peripheral Artery Disease Market, by Plaque Modification Devices, by Region, 2020-2034 (USD Billion)
    • 5.3.4. Stents
      • 5.3.4.1. Global Peripheral Artery Disease Market, by Stents, 2020-2034 (USD Billion)
    • 5.3.5. Atherectomy Devices
      • 5.3.5.1. Global Peripheral Artery Disease Market, by Atherectomy Devices, by Region, 2020-2034 (USD Billion)
    • 5.3.6. Guidewires and Sheaths
      • 5.3.6.1. Global Peripheral Artery Disease Market, by Guidewires and Sheaths, 2020-2034 (USD Billion)
    • 5.3.7. Other Devices
      • 5.3.7.1. Global Peripheral Artery Disease Market, by Other Devices, by Region, 2020-2034 (USD Billion)
  • 5.4. Drug Type
    • 5.4.1. Global Peripheral Artery Disease Market, by Drug Type, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Lipid-lowering Drugs
      • 5.4.2.1. Global Peripheral Artery Disease Market, by Lipid-lowering Drugs, 2020-2034 (USD Billion)
    • 5.4.3. Antiplatelet Drugs
      • 5.4.3.1. Global Peripheral Artery Disease Market, by Antiplatelet Drugs, by Region, 2020-2034 (USD Billion)
    • 5.4.4. Thrombolytic Agents
      • 5.4.4.1. Global Peripheral Artery Disease Market, by Thrombolytic Agents, 2020-2034 (USD Billion)
    • 5.4.5. Triple-H Therapy
      • 5.4.5.1. Global Peripheral Artery Disease Market, by Triple-H Therapy, by Region, 2020-2034 (USD Billion)
    • 5.4.6. Other Drugs
      • 5.4.6.1. Global Peripheral Artery Disease Market, by Other Drugs, 2020-2034 (USD Billion)

6. Global Peripheral Artery Disease Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 6.3. Hospital Pharmacy
    • 6.3.1. Global Peripheral Artery Disease Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
  • 6.4. Retail Pharmacy
    • 6.4.1. Global Peripheral Artery Disease Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Peripheral Artery Disease Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Peripheral Artery Disease Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • 7.3. Hospital
    • 7.3.1. Global Peripheral Artery Disease Market, by Hospital, by Region, 2020-2034 (USD Billion)
  • 7.4. Specialty Clinics
    • 7.4.1. Global Peripheral Artery Disease Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
  • 7.5. Ambulatory Surgical Centers
    • 7.5.1. Global Peripheral Artery Disease Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)

8. Global Peripheral Artery Disease Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Peripheral Artery Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Peripheral Artery Disease Market - North America
    • 8.3.1. North America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.3. North America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.3.4. Peripheral Artery Disease Market - U.S.
      • 8.3.4.1. U.S.: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.3.5. Peripheral Artery Disease Market - Canada
      • 8.3.5.1. Canada: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • 8.4. Peripheral Artery Disease Market - Europe
    • 8.4.1. Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.4. Peripheral Artery Disease Market - UK
      • 8.4.4.1. UK: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.5. Peripheral Artery Disease Market - France
      • 8.4.5.1. France: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.6. Peripheral Artery Disease Market - Germany
      • 8.4.6.1. Germany: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.7. Peripheral Artery Disease Market - Italy
      • 8.4.7.1. Italy: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.8. Peripheral Artery Disease Market - Spain
      • 8.4.8.1. Spain: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.9. Peripheral Artery Disease Market - Netherlands
      • 8.4.9.1. Netherlands: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.10. Peripheral Artery Disease Market - Russia
      • 8.4.10.1. Russia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.11. Peripheral Artery Disease Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • 8.5. Peripheral Artery Disease Market - Asia Pacific
    • 8.5.1. Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.4. Peripheral Artery Disease Market - China
      • 8.5.4.1. China: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.5. Peripheral Artery Disease Market - India
      • 8.5.5.1. India: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.6. Peripheral Artery Disease Market - Malaysia
      • 8.5.6.1. Malaysia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.7. Peripheral Artery Disease Market - Japan
      • 8.5.7.1. Japan: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.8. Peripheral Artery Disease Market - Indonesia
      • 8.5.8.1. Indonesia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.9. Peripheral Artery Disease Market - South Korea
      • 8.5.9.1. South Korea: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.10. Peripheral Artery Disease Market - Australia
      • 8.5.10.1. Australia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.11. Peripheral Artery Disease Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • 8.6. Peripheral Artery Disease Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.6.4. Peripheral Artery Disease Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.6.5. Peripheral Artery Disease Market - UAE
      • 8.6.5.1. UAE: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.6.6. Peripheral Artery Disease Market - Israel
      • 8.6.6.1. Israel: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.6.7. Peripheral Artery Disease Market - South Africa
      • 8.6.7.1. South Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.6.8. Peripheral Artery Disease Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • 8.7. Peripheral Artery Disease Market - Latin America
    • 8.7.1. Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.7.4. Peripheral Artery Disease Market - Mexico
      • 8.7.4.1. Mexico: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.7.5. Peripheral Artery Disease Market - Brazil
      • 8.7.5.1. Brazil: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.7.6. Peripheral Artery Disease Market - Argentina
      • 8.7.6.1. Argentina: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.7.7. Peripheral Artery Disease Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AngioDynamics
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. B. Braun SE
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bayer AG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. BD
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Biotronik
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Boston Scientific Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Cardinal Health
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Endologix LLC
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. iVascular
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Johnson & Johnson
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Koninklijke Philips N.V.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Medtronic
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Terumo Corporation
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development

List of Tables:

  • Table 1 Global Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 2 Global Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 3 Global Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 4 North America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 5 North America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 6 North America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 7 U.S.: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 9 U.S.: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 10 Canada: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 12 Canada: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 15 Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 16 UK: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 17 UK: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 18 UK: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 19 France: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 20 France: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 21 France: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 22 Germany: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 24 Germany: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Italy: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 27 Italy: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 28 Spain: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 30 Spain: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 34 Russia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 36 Russia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 43 China: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 44 China: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 45 China: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 46 India: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 47 India: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 48 India: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 52 Japan: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 54 Japan: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 58 South Korea: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 60 South Korea: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Australia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 63 Australia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 73 UAE: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 75 UAE: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 76 Israel: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 78 Israel: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 79 South Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 81 South Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 87 Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 88 Mexico: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 90 Mexico: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 91 Brazil: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 93 Brazil: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 94 Argentina: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 96 Argentina: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Peripheral Artery Disease Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Treatment Type
  • Figure 7. Global Peripheral Artery Disease Market, by Treatment Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Peripheral Artery Disease Market, by Distribution Channel, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End User
  • Figure 11. Global Peripheral Artery Disease Market, by End User, 2024 & 2034 (USD Billion)